Literature DB >> 8596548

The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age.

M L Reuss1, N Paneth, J A Pinto-Martin, J M Lorenz, M Susser.   

Abstract

BACKGROUND: Transient hypothyroxinemia, a common finding in premature infants, is not thought to have long-term sequelae or to require treatment. We investigated whether hypothyroxinemia in premature infants is a cause of subsequent motor and cognitive abnormalities.
METHODS: In this historical cohort study, we retrieved blood thyroxine values, obtained on routine screening in the first week of life, from state screening records on children who weighted 2000 g or less at birth, who were born at 33 weeks' gestation or earlier, and who were enrolled in a population-based study of the late sequelae of neonatal brain hemorrhage. We investigated the relation of these values to the odds for disabling cerebral palsy among 463 subjects for whom data were available and to the mental-development score on the Bayley Scales of Infant Development or the Stanford-Binet Intelligence Scales for Children at the age of two years in 400 subjects. The effects of severe hypothyroxinemia, defined as a blood thyroxine value more than 2.6 SD below the mean for New Jersey newborns, were assessed before and after adjustment for gestational age and potentially confounding variables.
RESULTS: In analyses adjusted for gestational age, infants with severe hypothyroxinemia had a risk of disabling cerebral palsy that was nearly 11 times that of infants without hypothyroxinemia (odds ratio, 10.8; 95 percent confidence interval, 3.0 to 39.3) and a mean mental-development score at the age of two that was 15.4 points lower (95 percent confidence interval, 8.1 to 22.6 points) than the mean score of children with normal neonatal blood thyroxine concentrations. After adjustment for gestational age and multiple prenatal, perinatal, and early and last neonatal variables, severe hypothyroxinemia was still associated with an increased risk of disabling cerebral palsy (odds ratio, 4.4; 95 percent confidence interval, 1.0 to 18.6) and a reduction of nearly 7 points (95 percent confidence interval, 0.3 to 13.2 points) in the mental-development score.
CONCLUSIONS: Severe hypothyroxinemia in preterm infants may be an important cause of problems in neurologic and mental development detected at the age of two years.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596548     DOI: 10.1056/NEJM199603283341303

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  40 in total

Review 1.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

2.  Free thyroxine levels after very preterm birth and neurodevelopmental outcomes at age 7 years.

Authors:  Shannon E Scratch; Rodney W Hunt; Deanne K Thompson; Zohra M Ahmadzai; Lex W Doyle; Terrie E Inder; Peter J Anderson
Journal:  Pediatrics       Date:  2014-03-31       Impact factor: 7.124

3.  Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months.

Authors:  Aleid van Wassenaer-Leemhuis; Susana Ares; Sergio Golombek; Joke Kok; Nigel Paneth; Jordan Kase; Edmund F LaGamma
Journal:  Thyroid       Date:  2014-05-21       Impact factor: 6.568

Review 4.  Maternal Hypothyroxinemia-Induced Neurodevelopmental Impairments in the Progeny.

Authors:  Hui Min; Jing Dong; Yi Wang; Yuan Wang; Weiping Teng; Qi Xi; Jie Chen
Journal:  Mol Neurobiol       Date:  2015-02-11       Impact factor: 5.590

5.  Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants.

Authors:  Verena Walsh; Jennifer Valeska Elli Brown; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2019-02-26

6.  Clinical dilemmas arising from the increased intake of iodine in the Spanish population and the recommendation for systematic prescription of potassium iodide in pregnant and lactating women (Consensus of the TDY Working Group of SEEN).

Authors:  F Soriguer; P Santiago; L Vila; J M Arena; E Delgado; F Díaz Cadórniga; S Donnay; M Fernández Soto; S González-Romero; P Martul; M Puig Domingo; S Ares; F Escobar del Rey; G Morreale de Escobar
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

Review 7.  Transient hypothyroidism in the newborn: to treat or not to treat.

Authors:  Neelakanta Kanike; Ajuah Davis; Prem S Shekhawat
Journal:  Transl Pediatr       Date:  2017-10

Review 8.  Is some white matter damage in preterm neonates induced by a human pestivirus?

Authors:  O Dammann; A Leviton
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

9.  Performance metrics after changes in screening protocol for congenital hypothyroidism.

Authors:  Steven J Korzeniewski; Violanda Grigorescu; Mary Kleyn; William Young; Gretchen L Birbeck; David Todem; Roberto Romero; Tinnakorn Chaiworapongsa; Nigel Paneth
Journal:  Pediatrics       Date:  2012-10-08       Impact factor: 7.124

10.  Role of late maternal thyroid hormones in cerebral cortex development: an experimental model for human prematurity.

Authors:  P Berbel; D Navarro; E Ausó; E Varea; A E Rodríguez; J J Ballesta; M Salinas; E Flores; C C Faura; G Morreale de Escobar
Journal:  Cereb Cortex       Date:  2009-10-07       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.